R&D Strong solutions for increasing dermatology research diversi... As a woman of colour, I am very careful about the skin care products I use. I must be.
R&D Worrying signs for trial diversity require broad industry ac... A recent report found that diversity in clinical trials has dropped.
Views & Analysis Inclusive research and tackling health inequalities Health inequalities are a long-term condition and inclusive research is the only disease modifying therapy in the pipeline – but how can the community drive practical change?
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
